Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-25-030712
Filing Date
2025-08-13
Accepted
2025-08-13 09:10:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4414
2 EXHIBIT A ef20053667_ex-a.htm EX-99.A 4553
  Complete submission text file 0001140361-25-030712.txt   10775
Mailing Address 605 THIRD AVENUE 38TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 38TH FLOOR NEW YORK NY 10158 212-610-6100
Nikko Asset Management Americas, Inc. (Filed by) CIK: 0001480751 (see all company filings)

EIN.: 941302123 | State of Incorp.: DE | Fiscal Year End: 0310
Type: SCHEDULE 13G

Mailing Address 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588
Business Address 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588 (925) 401-7300
10x Genomics, Inc. (Subject) CIK: 0001770787 (see all company filings)

EIN.: 455614458 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91164 | Film No.: 251209194
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)